Community partnerships lead to more inclusive health care for neurodiverse individuals

A new paper shows how partnering with the community can lead to more inclusive health care, especially for individuals with autism and other neurodevelopmental disabilities.

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischemic events in acute coronary syndrome (ACS) patients at high

August 29, 2023

64% of Women Want to Talk More About Their Health, Report Finds

What You Should Know: – A new report by Solera Health, a digital health platform, highlights a critical gap in communication surrounding women’s health. The

May 9, 2024

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Ovarian Cancer: Likelihood of Approval

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technology and currently in Phase II for Ovarian Cancer.

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.